Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CardioComm Solutions Inc V.EKG

Alternate Symbol(s):  EKGGF

CardioComm Solutions, Inc. is a global medical provider of consumer heart monitoring and medical electrocardiogram (ECG) software solutions. The Company’s technology is used in products for recording, viewing, analyzing and storing electrocardiograms for diagnosis and management of cardiac patients. It develops advanced software, hardware and core laboratory reading services related to ECG and ambulatory arrhythmia monitoring systems for medical and consumer markets globally. Its Global ECG Management Solutions (GEMS) and GlobalCardio (Cloud based GEMS) products are licensed worldwide to hospitals, ECG commercial reading services and physicians. The Company is also engaged in manufacturing, marketing, and sales of personal ECG monitors direct to consumers. The products are marketed under the HeartCheck brand. It has developed compatibility of the HeartCheck device to its GEMS and GlobalCardio based software to enable use of the device for remote ECG/arrhythmia monitoring services.


TSXV:EKG - Post by User

Bullboard Posts
Post by Steve888on Sep 28, 2018 5:43am
160 Views
Post# 28707017

News Highlights

News HighlightsIn terms of my understanding, the followings are some highlights from the news released in September 27, 2018:

(1) In light of the recent claims cited, the Company is issuing this press release for the benefit of its investors, shareholders, business partners and consumers;
(2) New
 hardware and software releases are near commercial release under the Heartcheck and GEMS Mobile brand;
(3) 
CardioComm is well positioned to assume a larger share of the Rx and OTC health and wellness markets;
(4) 
CardioComm considers the entry of new ECG monitoring hardware manufacturers to the sector;
(5) 
The Company believes that new partnerships between CardioComm and new device manufacturers will provide consumers access to products with a trusted ECG monitoring software backend;
(6) 
The Company believes that new partnerships will provide new entrants with shorter development timeframes and quicker product acceptance by consumers, physicians and patient monitoring/telemedicine organization.

As always, please read the news by yourself at:


https://web.tmxmoney.com/article.php?newsid=7727758639843844&qm_symbol=EKG


Bullboard Posts